Modulation of the Natural Killer Cell Compartment during DAAs treatment in Interferon-naïve HCV patients: The type of DAA matters.

[1]  H. Saito,et al.  On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C , 2017, PloS one.

[2]  R. D. de Knegt,et al.  The Path to Cancer and Back: Immune Modulation During Hepatitis C Virus Infection, Progression to Fibrosis and Cancer, and Unexpected Roles of New Antivirals. , 2017, Transplantation.

[3]  G. Foster,et al.  Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo , 2016, PLoS pathogens.

[4]  R. D. de Knegt,et al.  Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment. , 2016, The Journal of infectious diseases.

[5]  T. Liang,et al.  Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function. , 2015, Gastroenterology.

[6]  F. Marincola,et al.  Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus , 2015, Journal of Translational Medicine.

[7]  F. Locatelli,et al.  Human Natural Killer Cells: Origin, Receptors, Function, and Clinical Applications , 2014, International Archives of Allergy and Immunology.

[8]  D. Olive,et al.  Activating NK cell receptor expression/function (NKp30, NKp46, DNAM‐1) during chronic viraemic HCV infection is associated with the outcome of combined treatment , 2011, European journal of immunology.

[9]  L. Moretta,et al.  Increased natural cytotoxicity receptor expression and relevant IL‐10 production in NK cells from chronically infected viremic HCV patients , 2007, European journal of immunology.